HBI Deals+Insights / M&A/IPOs

Cinven’s €3 billion bet on labs

Cinven has placed a €3bn bet on the European diagnostic laboratory space, by agreeing to pay a higher than expected €1.85bn for synlab Group, a multiple of just over 12 times current EBITDA. It will combine synlab with Labco to create a truly Pan-European lab group with pro-forma 2014 sales of just over €1.4bn, nearly twice that of its nearest rival. But why bet €3bn on a sector where tariffs are falling and operators have no control over pricing? And could the French authorities block the deal?

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.